136 related articles for article (PubMed ID: 16151471)
1. Single-dose darbepoetin administration to anemic preterm neonates.
Warwood TL; Ohls RK; Wiedmeier SE; Lambert DK; Jones C; Scoffield SH; Neeraj G; Veng-Pedersen P; Christensen RD
J Perinatol; 2005 Nov; 25(11):725-30. PubMed ID: 16151471
[TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of darbepoetin to NICU patients.
Warwood TL; Ohls RK; Lambert DK; Jones C; Scoffield SH; Gupta N; Veng-Pedersen P; Christensen RD
J Perinatol; 2006 May; 26(5):296-300. PubMed ID: 16554846
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of darbepoetin after intravenous vs subcutaneous administration to preterm neonates.
Warwood TL; Ohls RK; Lambert DK; Leve EA; Veng-Pedersen P; Christensen RD
J Perinatol; 2006 Oct; 26(10):636-9. PubMed ID: 16929342
[TBL] [Abstract][Full Text] [Related]
4. A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants.
Ohls RK; Christensen RD; Kamath-Rayne BD; Rosenberg A; Wiedmeier SE; Roohi M; Lacy CB; Lambert DK; Burnett JJ; Pruckler B; Schrader R; Lowe JR
Pediatrics; 2013 Jul; 132(1):e119-27. PubMed ID: 23776118
[TBL] [Abstract][Full Text] [Related]
5. Very low birth weight infants qualifying for a 'late' erythrocyte transfusion: does giving darbepoetin along with the transfusion counteract the transfusion's erythropoietic suppression?
Warwood TL; Lambert DK; Henry E; Christensen RD
J Perinatol; 2011 Apr; 31 Suppl 1():S17-21. PubMed ID: 21448197
[TBL] [Abstract][Full Text] [Related]
6. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
[TBL] [Abstract][Full Text] [Related]
7. Effect of short-term erythropoietin therapy in anemic premature infants.
Reiter PD; Rosenberg AA; Valuck R; Novak K
J Perinatol; 2005 Feb; 25(2):125-9. PubMed ID: 15526012
[TBL] [Abstract][Full Text] [Related]
8. Enteral administration of recombinant erythropoietin to preterm infants.
Britton JR; Christensen RD
J Perinatol; 1995; 15(4):281-3. PubMed ID: 8558334
[TBL] [Abstract][Full Text] [Related]
9. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
10. Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients.
Jadoul M; Vanrenterghem Y; Foret M; Walker R; Gray SJ
Nephrol Dial Transplant; 2004 Apr; 19(4):898-903. PubMed ID: 15031347
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.
Hesketh PJ; Arena F; Patel D; Austin M; D'Avirro P; Rossi G; Colowick A; Schwartzberg L; Bertoli LF; Cole JT; Demetri G; Dessypris E; Dobbs T; Eisenberg P; Fleischman R; Hall J; Hoffman PC; Laber DA; Leonard J; Lester EP; McCachren S; McMeekin S; Meza L; Miller DS; Nand S; Oliff I; Paroly W; Pawl L; Perez A; Raftopoulos H; Rigas J; Rowland K; Scullin DC; Tezcan H; Waples J; Ward J; Yee LK
Cancer; 2004 Feb; 100(4):859-68. PubMed ID: 14770445
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis.
Allon M; Kleinman K; Walczyk M; Kaupke C; Messer-Mann L; Olson K; Heatherington AC; Maroni BJ
Clin Pharmacol Ther; 2002 Nov; 72(5):546-55. PubMed ID: 12426518
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
[TBL] [Abstract][Full Text] [Related]
16. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia.
Hernandez E; Ganly P; Charu V; Dibenedetto J; Tomita D; Lillie T; Taylor K;
Curr Med Res Opin; 2009 Sep; 25(9):2109-20. PubMed ID: 19601709
[TBL] [Abstract][Full Text] [Related]
18. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of renal anemia with darbepoetin alfa administered once every other week in predialysis patients with chronic kidney disease and previously treated with epoetin alfa].
Molina M; García Hernández MA; Navarro MJ; Pérez Silva F; Cacho M; De Gracia MC
Nefrologia; 2004; 24(1):54-9. PubMed ID: 15083958
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
